Case number 1:20-cv-01180
AstraZeneca AB et al v. Macleods Pharmaceuticals Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 26, 2020 | 11 | Proposed Consent Judgment (3) Docket Text: PROPOSED Consent Judgment, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) Modified on 10/26/2020 (nms). |
| Oct 26, 2020 | 12 | Consent Judgment (3) Docket Text: CONSENT JUDGMENT. Signed by Judge Richard G. Andrews on 10/26/2020. (nms) |
| Oct 26, 2020 | 13 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,300,065. (Attachments: # (1) Consent Judgment)(nms) |
| Oct 26, 2020 | 13 | Consent Judgment (3) |
| Oct 23, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: An answer was due to be filed on 10/15/2020 (see D.I. [9]), and to date none has been filed. Now the Plaintiff shall file a status letter within 3 days from the entry of this Order. Ordered by Judge Richard G. Andrews on 10/23/2020. (nms) |
| Oct 2, 2020 | 8 | Declaration (2) Docket Text: DECLARATION of Service of Defendant Macleods Pharmaceuticals Ltd. made on September 24, 2020, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Exhibits A-B)(Joyce, Alexandra) Modified on 10/2/2020 (nms). |
| Oct 2, 2020 | 8 | Exhibit A-B (7) |
| Oct 2, 2020 | 9 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. Macleods Pharma USA, Inc. served on 9/24/2020, answer due 10/15/2020. (Joyce, Alexandra) |
| Sep 9, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Sep 3, 2020 | 1 | Exhibit A (76) |
| Sep 3, 2020 | 1 | Civil Cover Sheet (3) |
| Sep 3, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Sep 3, 2020 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than 7/22/2020. Date of Expiration of Patent: 1/27/2036.Thirty Month Stay Deadline: No earlier than 1/23/2023. (nmg) |
| Sep 3, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,300,065. (nmg) |
| Sep 3, 2020 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB filed by AstraZeneca AB. (nmg) |
| Sep 3, 2020 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca Pharmaceuticals LP filed by AstraZeneca Pharmaceuticals LP. (nmg) |
| Sep 3, 2020 | 7 | Summons Issued - Electronic (4) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (nmg) |
| Sep 3, 2020 | 1 | Complaint* (1) |
